U.S. Spends More on Cancer Than Other Countries, but Without Mortality Benefit

WEDNESDAY, June 1, 2022 (HealthDay News) -- Although the cancer mortality rate in the United States is lower than the median for 22 high-income countries, the United States spends twice as much on cancer care as the median country, according to a study published online May 27 in JAMA Health Forum.
Ryan D. Chow, Ph.D., from the Yale School of Medicine in New Haven, Connecticut, and colleagues used data from 22 high-income countries to assess whether cancer mortality rates in 2020 were lower in countries with higher cancer-related spending and to estimate across countries the incremental cost per averted cancer death.
The researchers found that the median cancer mortality rate was 91.4 per 100,000 population and median per capita spending for cancer care overall was $296. The U.S. cancer mortality rate was higher than six other countries (86.3 per 100,000), yet the United States spends more than any other country ($584). Nine countries had lower cancer care expenditures and lower mortality rates than the United States when adjusting for smoking. Compared to four of the remaining 12 countries, the United States spent more than $5 million per averted death, and for the eight other countries, the United States spent between $1 and $5 million per averted death. There was no association observed between cancer care expenditures and cancer mortality rates, regardless of adjustments for smoking.
"Findings of this study suggest that the U.S. expenditure on cancer care may not be commensurate with improved cancer outcomes," the authors write.
One author disclosed financial ties to the biotechnology industry.
Related Posts
El estigma de la obesidad evita que muchas personas reciban pruebas de cáncer que salvan vidas: estudio
JUEVES, 19 de mayo de 2022 (HealthDay News) -- Muchas personas que tienen...
Polysubstance Use Common in Adults Seeking Substance Use Treatment
MONDAY, June 13, 2022 (HealthDay News) -- Past 30-day polysubstance use is...
Que el 2022 sea el año en que se haga una evaluación gratis de la memoria
DOMINGO, 2 de enero de 2022 (HealthDay News) -- Cuando se trata de las pruebas...
Clinically Relevant Benefits Seen for GLP-1RA, SGLTi Treatment of T1DM
THURSDAY, March 2, 2023 (HealthDay News) -- Glucagon-like peptide-1 receptor...